Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Goodwill & Intangibles (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Goodwill & Intangibles for 11 consecutive years, with $431000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 92.37% to $431000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $431000.0, a 92.37% decrease, with the full-year FY2025 number at $431000.0, down 92.37% from a year prior.
  • Goodwill & Intangibles was $431000.0 for Q4 2025 at Ekso Bionics Holdings, down from $4.6 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $5.7 million in Q4 2024 to a low of $431000.0 in Q2 2023.
  • A 4-year average of $2.9 million and a median of $2.5 million in 2023 define the central range for Goodwill & Intangibles.
  • Biggest YoY gain for Goodwill & Intangibles was 963.34% in 2025; the steepest drop was 92.37% in 2025.
  • Ekso Bionics Holdings' Goodwill & Intangibles stood at $5.6 million in 2022, then decreased by 5.75% to $5.3 million in 2023, then increased by 6.16% to $5.7 million in 2024, then tumbled by 92.37% to $431000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Goodwill & Intangibles are $431000.0 (Q4 2025), $4.6 million (Q3 2025), and $431000.0 (Q2 2025).